Cargando…

p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons

p53, initially considered a tumor suppressor, has been the subject of research related to cancer treatment resistance in the last 30 years. The unfavorable response to multimodal therapy and the higher recurrence rate, despite an aggressive approach, make HNSCC a research topic of interest for impro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mireștean, Camil Ciprian, Iancu, Roxana Irina, Iancu, Dragoș Petru Teodor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777383/ https://www.ncbi.nlm.nih.gov/pubmed/36553058 http://dx.doi.org/10.3390/diagnostics12123052

Ejemplares similares

New horizons in modulating the radio-sensitivity of head and neck cancer - 100 years after Warburg’ effect discovery
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Capecitabine—A “Permanent Mission” in Head and Neck Cancers “War Council”?
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Image Guided Radiotherapy (IGRT) and Delta (Δ) Radiomics—An Urgent Alliance for the Front Line of the War against Head and Neck Cancers
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Simultaneous Integrated Boost (SIB) vs. Sequential Boost in Head and Neck Cancer (HNC) Radiotherapy: A Radiomics-Based Decision Proof of Concept
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Active Immune Phenotype in Head and Neck Cancer: Reevaluating the Iso-Effect Fractionation Based on the Linear Quadratic (LQ) Model—A Narrative Review
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Radiomics in Triple Negative Breast Cancer: New Horizons in an Aggressive Subtype of the Disease
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Synergies Radiotherapy-Immunotherapy in Head and Neck Cancers. A New Concept for Radiotherapy Target Volumes—“Immunological Dose Painting”
por: Mireştean, Camil Ciprian, et al.
Publicado: (2020)

New Challenges of Treatment for Locally Advanced Head and Neck Cancers in the Covid-19 Pandemic Era
por: Mireștean, Camil Ciprian, et al.
Publicado: (2021)

Head and Neck Low Grade Chondrosarcoma—A Rare Entity
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Education in Radiation Oncology—Current Challenges and Difficulties
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Hypofractionated Whole-Breast Irradiation Focus on Coronary Arteries and Cardiac Toxicity—A Narrative Review
por: Mireştean, Camil Ciprian, et al.
Publicado: (2022)

An Underestimated Toxicity Radiation-Induced Hypothyroidism in Patients Multimodally Treated for Breast Cancer
por: Mireștean, Camil Ciprian, et al.
Publicado: (2021)

The Prognostic Value of Platelet–Lymphocyte Ratio, Neutrophil–Lymphocyte Ratio, and Monocyte–Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma (HNSCC)—A Retrospective Single Center Study and a Literature Review
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Immunotherapy and Radiotherapy as an Antitumoral Long-Range Weapon—A Partnership with Unsolved Challenges: Dose, Fractionation, Volumes, Therapeutic Sequence
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers—Early Experiences from Romania and Literature Review
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Radiotherapy challenges in COVID era
por: Mireștean, Camil Ciprian, et al.
Publicado: (2021)

Cancer and Diabetes: Predictive Factors in Patients with Metabolic Syndrome
por: Stan, Mihai Cosmin, et al.
Publicado: (2023)

Glycerol restores p53-dependent radiosensitivity of human head and neck cancer cells bearing mutant p53
por: Ohnishi, K, et al.
Publicado: (2000)

The in vitro radiosensitivity of human head and neck cancers.
por: BjÃ¶rk-Eriksson, T., et al.
Publicado: (1998)

Network-Based Predictors of Progression in Head and Neck Squamous Cell Carcinoma
por: Sanati, Nasim, et al.
Publicado: (2018)

Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors
por: Schrank, Travis P., et al.
Publicado: (2023)

The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers
por: Björk-Eriksson, T, et al.
Publicado: (1999)

Chromosomal radiosensitivity in head and neck cancer patients: evidence for genetic predisposition?
por: De Ruyck, K, et al.
Publicado: (2008)

Radiosensitization of head and neck cancer by targeting the epidermal growth factor receptor
por: Goel, Arun Kumar, et al.
Publicado: (2009)

Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck Cancer
por: Drobin, Kimi, et al.
Publicado: (2020)

Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2021)

Challenges in treating HIV-infected patient with disseminated Kaposi`s sarcoma and miliary TB
por: Iancu, Ana Maria, et al.
Publicado: (2014)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

Photodynamic Therapy as a Potent Radiosensitizer in Head and Neck Squamous Cell Carcinoma
por: Cho, Won Jin, et al.
Publicado: (2021)

Classical and multilinear harmonic analysis
por: Muscalu, Camil, et al.
Publicado: (2013)

Classical and multilinear harmonic analysis
por: Muscalu, Camil, et al.
Publicado: (2013)

Flaxseed Prevents Leukocyte and Platelet Adhesion to Endothelial Cells in Experimental Atherosclerosis by Reducing sVCAM-1 and vWF
por: Haliga, Raluca Ecaterina, et al.
Publicado: (2013)

Blood Group Type Association with Head and Neck Cancer
por: Alexandra, Gaube, et al.
Publicado: (2022)

The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer
por: Pattje, W J, et al.
Publicado: (2010)

In vitro and in vivo superior radiosensitizing effect of berbamine for head and neck squamous cell carcinoma
por: Zhu, Hongmei, et al.
Publicado: (2018)

Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data
por: Liu, Jie, et al.
Publicado: (2020)

M2 macrophages reduce the radiosensitivity of head and neck cancer by releasing HB-EGF
por: Fu, Enhui, et al.
Publicado: (2020)

MiR-125 family improves the radiosensitivity of head and neck squamous cell carcinoma
por: Wang, Qi-Wei, et al.
Publicado: (2023)

DNA damage response and potential biomarkers of radiosensitivity in head and neck cancers: clinical implications
por: Carpov, Domnica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_scs8d2c8ph6dngqe5ougoai5ms